Skip to main content
SpringerLink
Log in

Nutritional Management of Patients Undergoing Peritoneal Dialysis

  • Chapter
Peritoneal Dialysis

Abstract

Patients with chronic renal failure display a variety of metabolic and nutritional abnormalities and a large proportion of the patients demonstrate signs of protein-energy malnutrition [1–20]. This may be a consequence of multiple factors including disturbances in protein and energy metabolism, hormonal derangements, infections and other superimposed illnesses, and poor food intake because of anorexia, nausea and vomiting, caused by uremic toxicity. With maintenance dialysis therapy, some of these factors, but far from all, can be partly or fully corrected. On the other hand, metabolic and nutritional problems are caused by the method of dialysis. For example, the hemodialysis procedure per se may induce protein catabolism [8, 15, 16], peritoneal dialysis is associated with large protein losses into the dialysate [18, 19], and both dialysis methods are associated with dialytic losses of amino acids, vitamins, and other essential small solutes [20]. Futhermore, peritoneal dialysis is associated with absorption of large quantities of glucose from the dialysate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Emmanouel DS, Lindheimer MD, Katz Al: Metabolic and endocrine abnormalities in chronic renal failure, In: Brenner BM, Stein JH (eds), Chronic Renal Failure, New York, Churchill Livingstone, p 46–83, 1981.

    Google Scholar 

  2. Alvestrand A, Bergström J: Nutritional management, In Suki WN, Massry SG (eds), Therapy of Renal Diseases and Related Disorders, Boston, Martinus Nijhoff Publishers, p 459–480, 1984.

    Google Scholar 

  3. Kopple JD: Abnormal amino acid and protein metabolism in uremia. Kidney Int 14: 340–348, 1978.

    Article  PubMed  CAS  Google Scholar 

  4. Smith D, DeFronzo RA: Endocrine dysfunction in chronic renal failure, In Nissenson AR, Fine RN, Gentile DF (eds), Clinical Dialysis, Norwalk, Connecticut, Appleton-Century-Crofts,p 451–497, 1984.

    Google Scholar 

  5. Guarnieri G, Faccini L, Lipartiti T, Ranieri F, Spangaro F, Giuntini D. Toigo G, Dardi F, Vivaldi FB, Raimondi A: Simple methods for nutritional assessment in hemodialyzed patients. Am J Clin Nutr 33: 1598–1607, 1980.

    PubMed  CAS  Google Scholar 

  6. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Shen FH, Gandhi VC, Tucker CT, Curtis FK, Coburn JW: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33: 1567–1585, 1980.

    PubMed  CAS  Google Scholar 

  7. Guarnieri G, Toigo G, Situlin R, Faccini L, Coli U, Landini S, Bazzato G, Dardi F, Campanacci L: Muscle biopsy in chronically uremic patients: Evidence for malnutrition. Kidney Int 24, Suppl 16: S187–193, 1983.

    Google Scholar 

  8. Borah M, Schoeneld PY, Gotch FA, Sargent JA, Wolfson M, Humphreys MH: Nitrogen balance in intermittent hemodialysis therapy. Kidney Int 14: 491–500, 1978.

    Article  PubMed  CAS  Google Scholar 

  9. Kluthe R, Luttgen FM, Capetianu T, Heine V, Katz N, Sudhoff A: Protein requirements in maintenance hemodialysis. Am J Clin Nutr 31: 1812–1820, 1978.

    PubMed  CAS  Google Scholar 

  10. Thunberg BJ, Swamy AP, Cestero RV: Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 34: 2005–2012, 1981.

    PubMed  CAS  Google Scholar 

  11. Young GA, Swanepoel CR, Croft MR, Hobson SM: Anthropometry and plasma valine, amino acids and proteins in the nutritional assessment of hemodialysis patients. Kidney Int 21:492–499, 1982.

    Article  PubMed  CAS  Google Scholar 

  12. Schoenfeld PY, Henry RR, Laird NM, Roxe DM: Assessment of nutritional status of the national cooperative dialysis study population. Kidney Int 23, Suppl 13: S-80–S-88, 1983.

    Google Scholar 

  13. Bergström J, Alvestrand A, Fürst P, Hultman E, Widstam-Attorps U: Muscle intracellular electrolytes in patients with chronic uremia. Kidney Int 24, Suppl 16: S-153–S-160, 1983.

    Google Scholar 

  14. Wolfson M, Strong CJ, Minturn D, Gray DK, Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 37: 547–555, 1984.

    Google Scholar 

  15. Farrell PC, Hone PW: Dialysis-induced catabolism. Am J Clin Nutr 33: 1417–1422, 1980.

    PubMed  CAS  Google Scholar 

  16. Ward RA, Shirlow M J, Hayes JM, Chapman GV, Farrell PC: Protein catabolism during hemodialysis. Am J Clin Nutr 32: 2443–2449, 1979.

    PubMed  CAS  Google Scholar 

  17. Ahmad S, Gallagher N, Shen F: Intermittent peritoneal dialysis: Status reassessed. Trans Am Soc Artif Intern Organs 25: 86–88,1979.

    PubMed  CAS  Google Scholar 

  18. Blumenkrantz MJ, Salusky IB, Schmidt RW: Managing the nutritional concerns of the patient undergoing peritoneal dialysis, In: Nolph KD (ed), Peritoneal dialysis. Boston, Martinus Nijhoff Publishers, pp 345–401, 1985.

    Google Scholar 

  19. Khanna R, Oreopoulos DG: Complications of peritoneal dialysis other than peritonitis, In: Nolph KD (ed), Peritoneal Dialysis. Boston, Martinus Nijhoff Publishers, pp 441–524, 1985.

    Google Scholar 

  20. Bergström J: Protein catabolic factors in patients on renal replacement therapy. In-depth Review. Blood Purif 3: 215–236, 1985.

    Article  PubMed  Google Scholar 

  21. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24, Suppl 16: S-199–S-203, 1983.

    Google Scholar 

  22. Harter HR: Review of significant findings from the national cooperative dialysis study and recommendations. Kidney Int 23, Suppl 13: S-107–S-112, 1983.

    Google Scholar 

  23. Ganter G: Über die Beseitigung giftiger Stoffe aus dem Blut durch Dialysis. Munch Med Wochenschr 70:1478–1480,1923.

    Google Scholar 

  24. Boen ST: Peritoneal dialysis. Thesis. University of Amsterdam, The Netherlands, 1959.

    Google Scholar 

  25. Gokal R: Historical development and clinical use of continuous ambulatory peritoneal dialysis, In: Gokal R (ed), Continuous Ambulatory Peritoneal Dialysis. London, Churchill Livingstone, pp 1–13, 1986.

    Google Scholar 

  26. Tenckhoff H, Schechter H: A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 14: 181–186, 1968.

    PubMed  CAS  Google Scholar 

  27. Oreopoulos DG: Chronic peritoneal dialysis. Clin Nephrol 9:165–173, 1978.

    PubMed  CAS  Google Scholar 

  28. Popovich RP, Moncrief JW, Decherd JF, Bomar JB, Pyle WK: The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. Abstr. Trans Am Soc Artif Intern Organs 5: 64, 1976.

    Google Scholar 

  29. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twar-dowski ZJ, Pyle WK: Continuous ambulatory peritoneal dialysis. Ann Intern Med 88: 449–456, 1978.

    PubMed  CAS  Google Scholar 

  30. Nolph KD, Popovich RP, Moncrief JW: Theoretical and practical implications of continuous ambulatory peritoneal dialysis. Nephron 21: 117–122, 1978.

    Article  PubMed  CAS  Google Scholar 

  31. Oreopoulos DG, Robson M, Izatt S, Clayton S, De Veber GA: A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24: 484–489, 1979.

    Google Scholar 

  32. Bergström J: Potential metabolic problems associated with continuous ambulatory peritoneal dialysis, In: Legrain M (ed), Continuous Ambulatory Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 277–282, 1980.

    Google Scholar 

  33. Kopple JD, Blumenkrantz MJ: Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 24, Suppl 16: S-295–S-302, 1983.

    Google Scholar 

  34. Wu G, Kim D, Oreopoulos DG: Efficacy and adequacy of continuous ambulatory peritoneal dialysis. In: Robinson RR (ed), Nephrology. Vol. II, New York, Springer-Verlag, pp 1581–1610, 1984.

    Google Scholar 

  35. Lindholm B, Alvestrand A, Norbeck HE, Tranaeus A, Bergström J: Long-term metabolic consequences of continuous ambulatory peritoneal dialysis, In: Robinson RR (ed), Nephrology. Vol. II, New York, Springer Verlag, pp 1611–1626, 1984.

    Google Scholar 

  36. Lindholm B, Bergström J: Nutritional aspects of CAPD, In: Gokal R (ed), Continuous Ambulatory Peritoneal Dialysis. London, Churchill Livingstone, pp 228–264, 1986.

    Google Scholar 

  37. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 31: 103–110, 1982.

    Article  PubMed  CAS  Google Scholar 

  38. Shapiro JI, Argy WP, Rakowski TA, Chester A, Siemsen AS, Schreiner GE: The unsuitability of BUN as a criterion for prescription dialysis. Trans Am Soc Artif Intern Organs 29: 129–134, 1983.

    PubMed  CAS  Google Scholar 

  39. Bansal VK, Popli S, Pickering J, Ing TS, Vertuno LL, Kano JF: Protein-calorie malnutrition and cutaneous anergy in hemodialysis maintained patients. Am J Clin Nutr 33: 1608–1611, 1980.

    PubMed  CAS  Google Scholar 

  40. Mattern WD, Hak LJ, Lamanna RW, Teasley KM, Laffell MS: Malnutrition, altered immune function, and the risk of infection in maintenance hemodialysis patients. Am J Kidney Dis 1:206–218, 1982.

    PubMed  CAS  Google Scholar 

  41. Sengar DPS, Rashid A, Harris JF: In vitro cellular immunity and in vivo delayed hypersensitivity in uremic patients maintained on hemodialysis. Int Archs Allergy appi. Immun 47: 839, 1974.

    Article  Google Scholar 

  42. Corey PN, Steele C: Risk factors associated with time to first infection and time to failure on CAPD. Perit Dial Bull 3 (Suppl3):S14–S18.

    Google Scholar 

  43. Young GA, Young JB, Young SM, Hobson SM, Hildreth B, Brownjohn AM, Parsons FM: Nutrition and Delayed Hypersensitivity during Continuous Ambulatory Peritoneal Dialysis in Relation to Peritonitis. Nephron 43:177–186, 1986.

    Article  PubMed  CAS  Google Scholar 

  44. Delaporte C, Gros F, Anagnostopoulos T: Inhibitory effects of plasma dialysate on protein synthesis in vitro influence of dialysis and transplantation. Am J Clin Nutr 33: 1407–1410, 1980.

    PubMed  CAS  Google Scholar 

  45. Flugel-Link RM, Salusky IB, Jones MR, Kopple JD: Protein and amino acid metabolism in posterior hemicorpus of acutely uremic rats. Am J Physiol 244: E615–623, 1983.

    PubMed  CAS  Google Scholar 

  46. Kopple JD: Nutrition in renal failure. Causes of catabolism and wasting in acute or chronic renal failure. In: Robinson R (ed), Nephrology. Vol. II, Proc IXth Int Cong Nephrol, New York, Springer-Verlag, pp 1499–1515, 1985.

    Google Scholar 

  47. Cernaeck P. Spustova V, Dzurik R: Inhibitor(s) of protein synthesis in uremic serum and urine: partial purification and relationship to amino acid transport. Biochem Med 27: 305–316, 1982.

    Article  Google Scholar 

  48. Garber AJ: Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat. J Clin Invest 62: 623–632, 1978.

    Article  PubMed  CAS  Google Scholar 

  49. Harter HR, Karl IE, Klahr S, Kipnis DM: Effects of reduced renal mass and dietary protein intake amino acid release and glucose uptake by rat muscle in vitro. J Clin Invest 64: 513–523,1979.

    Article  PubMed  CAS  Google Scholar 

  50. DeFronzo RA, Smith D, Alvestrand A: Insulin resistance in uremia is specific for glucose metabolism. Kidney Int 23: 222, 1983.

    Google Scholar 

  51. Conley SB, Rose GM, Robson Am, Bier DM: Effects of dietary intake and hemodialysis on protein turnover in uremic children. Kidney Int 17: 827–846, 1980.

    Article  Google Scholar 

  52. Goodship THJ, Lloyd S, Clague MB, Bartlett K, Ward MK, Wilkinson R: Whole body leucine turnover and nutritional status in continuous ambulatory peritoneal dialysis. Clin Sci 73: 463–469, 1987.

    PubMed  CAS  Google Scholar 

  53. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL: Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin 1). New Engl J Med 308: 553–558, 1983.

    Article  PubMed  CAS  Google Scholar 

  54. Hörl WH, Stepinski J, Schäfer RM, Wanner C, Heidland A: Role of proteases in hypercatabolic patients with renal failure. Kidney Int 24: suppl 16, pp 37–42, 1983.

    Google Scholar 

  55. Shaldon S, Koch KM, Quellhorst E, Dinarello CA: Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Internal Organs 30: 193–194, 1984.

    CAS  Google Scholar 

  56. Gulyassy PF, Aviram A, Peters JH: Evaluation of amino acid and protein requirements in chronic uremia. Archs Intern Med 126: 855–859, 1970.

    Article  CAS  Google Scholar 

  57. Young GA, Parsons FM: Plasma amino acid imbalance in patients with chronic renal failure on intermittent dialysis. Clinica chim. Acta 27: 491–496, 1970.

    Article  CAS  Google Scholar 

  58. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler F, Wahren J: Insulin resistance in uremia. J Clin Invest 67: 563–568, 1981.

    Article  PubMed  CAS  Google Scholar 

  59. Arnold W, Holliday MA: In vitro suppression of insulin-mediated amino acid uptake in uremic skeletal muscle. Am J Clin Nutr 33: 1428–1432, 1980.

    PubMed  CAS  Google Scholar 

  60. Phillips LS, Pennisi AJ, Belosky DC: Somatomedin activity and in-organic sulfate in children undergoing dialysis. J Clin Endocr Metab 46: 165–168, 1978.

    Article  PubMed  CAS  Google Scholar 

  61. Phillips LS, Kopple JD: Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. Metabolism 30: 1091–1095, 1981.

    Article  PubMed  CAS  Google Scholar 

  62. Sherwin RS, Basil C, Finkelstein FO, Fisher M, Black H, Hendler R, Felig P: Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon. J Clin Invest 57: 722–731, 1976.

    Article  PubMed  CAS  Google Scholar 

  63. Moxley MA, Bell NH, Wagle SR, Allen DO, Ashmore J: Parathyroid hormone stimulation of glucose and urea production in isolated liver cells. Am J Physiol 227: 1058–1061, 1974.

    PubMed  CAS  Google Scholar 

  64. Grodstein GP, Harrison A, Roberts C, Ippitili A, Kopple JD: Impaired gastric emptying in hemodialysis patients (Abstract). Kidney Int 16: 952A, 1979.

    Google Scholar 

  65. Drukker A, Levy E, Bronza N, Stankiewich H, Goldstein R: Impaired intestinal fat absorption in chronic renal failure. Nephron 30: 154–160, 1982.

    Article  PubMed  CAS  Google Scholar 

  66. Williams P, Kay R, Harrison J, McNeil K, Petit J, Kelman B, Mendez M, Klein M, Ogilvie R, Khanna R, Carmichael D, Oreopoulos DG: Nutritional and anthropometric assessment of patients on CAPD over one year: contrasting changes in total body nitrogen and potassium. Peritoneal Dial Bull 1:82–87, 1981.

    Google Scholar 

  67. Heide B, Pierratos A, Khanna R, Petit J, Ogilvie R, Harrison J, McNeil K, Siccion Z, Oreopoulos DG: Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Peritoneal Dial Bull 3: 138–141, 1983.

    Google Scholar 

  68. Oreopoulos DG, Marliss E, Anderson GH, Oren A, Dombros N, Williams P, Khanna R, Rodella H, Brandes L: Nutritional aspects of CAPD and the potential use of amino acid containing dialysis solutions. Peritoneal Dial Bull 3: 10–15, 1983.

    Google Scholar 

  69. Lindholm B, Karlander SG, Norbeck HE, Bergström J: Hormonal and metabolic adaptation to the glucose load of CAPD in non-diabetic patients; in Keen, Legrain, Prevention and treatment of diabetic nephropathy, pp 353–359, MTP Press, Boston, 1983.

    Google Scholar 

  70. Randerson DH, Farrell PC: Metabolic generation and clearance variation in long-term CAPD; In: Moncrief, Popovich, CAPD Update, pp 75–81 (Masson, New York 1981).

    Google Scholar 

  71. Lindholm B, Ahlberg M, Alvestrand A, Fürst P, Tranaeus A, Bergström J: Nitrogen balance and protein and energy intake during CAPD, (Abstract). 4th Int Congr on Nutrition and Metabolism in Renal Disease, Williamsburg, 1985.

    Google Scholar 

  72. Von Baeyer H, Gahl GM, Riedinger H, Borowzak R, Aver-donk R, Schurig R, Kessel M: Adaptation of CAPD patients to the continuous peritoneal energy uptake. Kidney Int 23: 29–34, 1983.

    Article  Google Scholar 

  73. Gahl GM, Von Baeyer H, Riedinger R, Borowzak B, Schurig R, Becker H, Kessel M: Caloric intake and nitrogen balance in patients undergoing CAPD; In: Moncrief, Popovich, CAPD Update, pp 87–93 (Masson, New York 1981).

    Google Scholar 

  74. Grodstein GP, Blumenkrantz MJ, Kopple JD: Nutritional and metabolic response to catabolic stress in uremia. Am J Clin Nutr 33: 1411–1416, 1980.

    PubMed  CAS  Google Scholar 

  75. Rubin J, Flynn MA, Nolph KD: Total body potassium — a guide to nutritional health in patients undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 34: 94–98, 1981.

    PubMed  CAS  Google Scholar 

  76. Rubin J, Kirchner K, Barnes T, Teal N, Ray R, Bower JD: Evaluation of continuous ambulatory peritoneal dialysis. Am J Kidney Dis 3: 199–204, 1983.

    PubMed  CAS  Google Scholar 

  77. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 19: 593–602, 1981.

    Article  PubMed  CAS  Google Scholar 

  78. Lindholm B, Alvestrand A, Fürst P, Tranaeus A, Bergström J: Efficacy and clinical experience of CAPD — Stockholm, Sweden; In: Atkins, Thomson, Farrell, Peritoneal Dialysis, pp 147–161 (Churchill Livingstone, Edinburgh 1981).

    Google Scholar 

  79. Randerson DH, Chapman GV, Farrell PC: Amino acid and dietary status in CAPD patients. In: Atkins, Thomson, Farrell, Peritoneal Dialysis, pp 179–191 (Churchill Livingstone, Edinburgh 1981).

    Google Scholar 

  80. Nolph KD, Sorkin M, Rubin J, Arfania D, Porwant B, Fruto L, Kennedy D: Continuous ambulatory peritoneal dialysis. Three-year experience at one center. Ann. Intern Med 92: 609–613, 1980.

    PubMed  CAS  Google Scholar 

  81. Randerson DH, Farrell PC: Clinical assessment of CAPD. Dial Transplant 10: 389–398, 1981.

    Google Scholar 

  82. Gahl GM, Schurig R, Becker H, Sorge F, Pustelnik A, Borowzak B, Riedinger R, Von Baeyer H, Kessel M: Clinical and metabolic aspects of continuous ambulatory peritoneal dialysis (CAPD). Int J Artif Organs 3: 245–249, 1980.

    PubMed  CAS  Google Scholar 

  83. Katirtzoglou A, Oreopoulos DG, Husdan H, Leung M, Ogilvie R, Dombros N: Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis. Nephron 26: 230–233, 1980.

    Article  PubMed  CAS  Google Scholar 

  84. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 19: 593–602, 1981.

    Article  PubMed  CAS  Google Scholar 

  85. Rubin J, Nolph KD, Arfania D, Prowant B, Fruto L, Brown P, Moore H: Protein losses in continuous ambulatory peritoneal dialysis. Nephron 28: 218–221, 1981.

    Article  Google Scholar 

  86. Kaysen GA, Schoenfeldt PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 25: 107–114, 1984.

    Article  PubMed  CAS  Google Scholar 

  87. Dulaney JT, Hatch FE: Peritoneal dialysis and loss of proteins: a review. Kidney Inty 26: 253–262, 1984.

    Article  CAS  Google Scholar 

  88. Diaz-Buxo JA: Intermittent, continuous ambulatory and continuous cycling peritoneal dialysis. In: Nissenson, Fine, Gentile, Clinical dialysis, pp 263–306 (Appleton-Century-Crofts, Norwalk 1984).

    Google Scholar 

  89. Young GA, Brownjohn AM, Parsons FM: Protein Losses in Patients Receiving Continuous Ambulatory Peritoneal Dialysis. Nephron 45: 196–201, 1987.

    Article  PubMed  CAS  Google Scholar 

  90. Rubin J, Walsh D, Bower JD: Diabetes, Dialysate Losses, and Serum Lipids During Continuous Ambulatory Peritoneal Dialysis. Am J Kidney Dis 10: 104–108, 1987.

    PubMed  CAS  Google Scholar 

  91. Miller FN, Hammerschmidt DE, Anderson GL, Moore JN: Protein loss induced by complement activation during peritoneal dialysis. Kidney Int 25: 480–485, 1984.

    Article  PubMed  CAS  Google Scholar 

  92. Shaldon S: Peritoneal macrophage — the first line of defense, In: La Greca G (ed), Proc Second Int Course on Peritoneal Dialysis. Milano, Wichtig Editore, 1985 (in press).

    Google Scholar 

  93. Leichter HE, Salusky IB, Wilson M, Hall T, Jordan SC, Ettenger RB, Fine RN: 3 1/3 years experience with peritonitis in children undergoing CAPD and CCPD (Abstract) Perit Dial Bull 4 (suppl): S36, 1984.

    Google Scholar 

  94. Boesken WH, Schuppe HC, Seidler A, Schollmeyer P: Peritoneal membrane permeability for high and low molecular weight protein (H/LMWP) under CAPD, In: Maher JF, Winchester JF (eds), Frontiers in Peritoneal Dialysis. New York, Field, Rich and Assoc, Inc., pp 47–52, 1986.

    Google Scholar 

  95. Bannister DK, Acchiardio SR, Moore LW, Kraus AP: Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients. J Am Diet Ass 87: 53–56,1987.

    CAS  Google Scholar 

  96. Rubin J, Deraps GD, Walsh D, Adair C, Bower J: Protein Losses and Tobramycin Absorption in Peritonitis Treated by Hourly Peritoneal Dialysis. Am J Kidney Dis 8: 124–127, 1986.

    PubMed  CAS  Google Scholar 

  97. Staprans I, Piel CF, Felts JM: Analysis of Selected Plasma Constituents in Continuous Ambulatory Peritoneal Dialysis Effluent. Am J Kidney Dis 7: 490–494, 1986.

    PubMed  CAS  Google Scholar 

  98. Berlyne GM, Lee HA, Giordano C, Pascale C de, Esposito R: Amino acid loss in peritoneal dialysis. Lancet i: 1339, 1967.

    Article  CAS  Google Scholar 

  99. Noree LO, Bergström J, Fürst P, Hallgren B: The effect of essential amino acid administration on nitrogen metabolism during dialysis. Proc Eur Dial Transplant Ass 8: 182, 1971.

    Google Scholar 

  100. Young GA, Parsons FM: The effect of peritoneal dialysis upon the amino acids and other nitrogenous compounds in the blood and dialysate of patients with renal failure. Clin Sci 37: 1, 1968.

    Google Scholar 

  101. Finkelstein AS, Kliger AS: Chronic peritoneal dialysis in diabetic patients with end-stage renal failure. Proc Clin Dial Transplant Forum 5: 142, 1975.

    PubMed  CAS  Google Scholar 

  102. Armstrong VW, Buschmann U, Ebert R, Fuchs C, Rieger J, Scheler F: Biochemical investigations of CAPD: plasma levels of trace elements and amino acids and impaired glucose tolerance during the course of treatment. Int J Artif Org 3:237–241, 1980.

    CAS  Google Scholar 

  103. Von Baeyer H, Gahl GM, Riedinger H, Borowzak B, Kessel M: Nutritional behaviour of patients on continuous ambulatory peritoneal dialysis. Proc EDTA 18: 193–198, 1981.

    Google Scholar 

  104. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 36: 395–402, 1982.

    PubMed  CAS  Google Scholar 

  105. Giordano C, De Santo NG, Capodicasa G, Die Leo VA, Di Serafino A, Cirillo D, Esposito R, Fiore R, Damiano M, Buonadonna L, Cocco F, Di Iorio B: Amino acid losses during CAPD. Clin Nephrol 14: 230–232, 1980.

    PubMed  CAS  Google Scholar 

  106. Fürst P, Bergström J, Lindholm B: Studies of amino-acid metabolism in continuous ambulatory peritoneal dialysis patients — preliminary results, In: Legrain M (ed), Continuous Ambul;atory Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 292–2907, 1980.

    Google Scholar 

  107. Dombros N, Oren A, Marliss EB, Anderson GH, Stein AN, Khanna R, Petit J, Brandes L, Rodella H, Leibel BS, Oreopoulos D: Plasma amino acid profiles and amino acid losses in patients undergoing CAPD. Perit Dial Bull 2: 27–32,1982.

    Google Scholar 

  108. Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21: 849–864, 1982.

    Article  PubMed  CAS  Google Scholar 

  109. De Santo NG, Capodicasa G, Di Leo VA, Di Serafino A, Cirillo D, Esposito R, Fiore R, Cucciniello E, Damiano M, Buonadonna L, Di Iorio R, Capasso G, Giordano C: Kinetics of amino acids equilibration in the dialysate during CAPD. Int J Artif Organs 4: 23–30, 1981.

    PubMed  Google Scholar 

  110. Kopple JD, Monteon FJ, Shaib JK: Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int 29: 734–742, 1986.

    Article  PubMed  CAS  Google Scholar 

  111. Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD: Energy expenditure in patients with chronic renal failure. Kidney Int 30: 741–747, 1986.

    Article  PubMed  CAS  Google Scholar 

  112. Brautbar N: Skeletal myopathy in uremia: Abnormal energy metabolism. Kidney Int 24 (Suppl 16): S81–S86, 1983.

    Google Scholar 

  113. Smith D, DeFronzo RA: Insulin resistance in uremia mediated by postbinding defects. Kidney Int 22: 5462, 1982.

    Article  Google Scholar 

  114. May RC, Clark AS, Goheer MA, Mitch WE: Specific defects in insulin-mediated muscle metabolism in acute uremia. Kidney 28: 490–497, 1985.

    Article  CAS  Google Scholar 

  115. Guarnieri G, Toigo G, De Marchi S et al: Muscle hexokinas and phosphofructokinase activity in chronically uremic patients. In: Giordano C, Friedman EA (eds). Uremia: Pathobiology of patients treated for 10 years or more, Milano: Wichtig Editore, 278–282, 1981.

    Google Scholar 

  116. Metcoff J, Dutta A, Burns G et al: Effects of amino acid infusions on cell metabolism in hemodialyzed patient with uremia. Kidney Int 24 (Suppl 16): 87–92, 1983.

    CAS  Google Scholar 

  117. Bertoli M, Baltistella PA, Vergani et al: Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. Am J Clin Nutr 34: 1496–1500, 1981.

    PubMed  CAS  Google Scholar 

  118. Bergström J, Lindholm B, Alvestrand A, Hultman E: Muscle composition in CAPD patients. In: La Greca G, Chiaramonte S, Fabris A, Feriani M, Ronco C (eds), Peritoneal Dialysis. Milano: Wichtig Editore, pp 107–110, 1986.

    Google Scholar 

  119. Lindholm B, Hultman E, Bergström J: Skeletal muscle low-energy state in CAPD. In: Proc. IV Congr Int Soc Perit Dial, 1987 (in press).

    Google Scholar 

  120. Metcoff J, Pederson J, Gable J, Llach F: Protein synthesis, cellular amino acids, and energy levels in CAPD patients. Kidney Int 32 (Suppl 22): S136–S144, 1987.

    Google Scholar 

  121. Quintanilla AP, Sahgal V. Uremic myopathy. Int J of Artif Organs 7: 239–242, 1984.

    Google Scholar 

  122. Del Canale S, Fiaccadori E, Ronda N, Söderlund K, Antonucci C, Guariglia A: Muscle energy metabolism in uremia. Metabolism 35: 981–983, 1986.

    Article  PubMed  Google Scholar 

  123. Westervelt FB: Insulin effect in uremia. J Lab Clin Med 74: 79–84, 1969.

    PubMed  CAS  Google Scholar 

  124. DeFronzo RA, Andres R, Edgar P, Walker WG: Carbohydrate metabolism in uremia: A review. Medicine 52: 469–481,1973.

    Article  PubMed  CAS  Google Scholar 

  125. DeFronzo RA, Tobin JD, Rowe JW, Andres R: Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62: 425–435, 1978.

    Article  PubMed  CAS  Google Scholar 

  126. Rubenfeldt S, Garber AJ: Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal. J Clin Invest 62: 20–28, 1978.

    Article  Google Scholar 

  127. Massry SG: The toxic effects of parathyroid hormone in uremia. Sem in Nephrol 3: 306–328, 1983.

    CAS  Google Scholar 

  128. Bilbrey GL, Faloona GR, White MG, Knochel JP: Hyper-glucagonemia of renal failure. J Clin Invest 53: 841–847, 1974.

    Article  PubMed  CAS  Google Scholar 

  129. De Santo NG, Capodicasa G, Denatore R, Cicchetti T, Cirillo D, Damiano M, Torella R, Giugliano D, Improta L, Giordano C: Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis (CAPD). Int J Artif Org 2: 119–124. 1979.

    Google Scholar 

  130. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19: 564–567, 1981.

    Article  PubMed  CAS  Google Scholar 

  131. Keusch G, Bammatter F, Mordasini R, Binswanger U: Serum lipoprotein concentrations during continuous ambulatory peritoneal dialysis (CAPD), In: Gahl GM, Kessel M, Nolph KD (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 427–429, 1981.

    Google Scholar 

  132. Lindholm B, Karlander SG, Norbeck HE, Fürst P, Bergström J: Carbohydrate and lipid metabolism in CAPD patients, In: Atkins R, Thomson N, Farrell P (eds), Peritoneal Dialysis. Edinburgh, Churchill Livingstone, pp 198–210, 1981.

    Google Scholar 

  133. Splendiani G, Acitelli S, Albano V, Gianforte A, Tancredi M: Metabolic aspects of CAPD, In: Gahl GM, Kessel M, Nolph KD (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 449–451, 1981.

    Google Scholar 

  134. Von Baeyer H, Gahl GM, Riedinger H, Borowzak R, Aver-dunk R, Schurig R, Kessel M; Adaptation of CAPD patients to the continuous peritoneal energy uptake. Kidney Int 23: 29–34, 1983.

    Article  Google Scholar 

  135. Rubin J, Ray R, Barnes T, Bower J: Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Nephron 29: 124–127, 1981.

    Article  PubMed  CAS  Google Scholar 

  136. Verger C, Larpent L, Dumontet M: Prognostic value of peritoneal equilibration curves (EC) in CAPD patients, In: Maher JF, Winchester JF (eds), Frontiers in Peritoneal Dialysis. New York, Field, Rich and Assoc, Inc., pp 88–93, 1986.

    Google Scholar 

  137. Smeby LC, Wideröe TE, Jörstad S: Individual differences in water transport during continuous peritoneal dialysis. ASAIO J 4: 17–27, 1981.

    Google Scholar 

  138. Passlick J, Frank A, Berger M,. Grabensee B: Alteration in glucose absorption during peritonitis and its effects in diabetic and nondiabetic patients undergoing CAPD. (Abstract) Perit Dial Bull 4 (suppl): S48, 1984.

    Google Scholar 

  139. Manuel MA: Failure of ultrafiltration in patients on CAPD. Perit Dial Bull 3 (suppl): S38–40, 1983.

    Google Scholar 

  140. Henderson L: Ultrafiltration with peritoneal dialysis, In: Nolph KD (ed), Peritoneal Dialysis. Boston, Martinus Nijhoff Publishers, pp 158–177, 1985.

    Google Scholar 

  141. Nolph KD, Ryan L, Moore RH, Legrain M, Mion C, Oreopoulos DG: Factors affecting ultrafiltration in continuous ambulatory peritoneal dialysis. Perit Dial Bull 4: 14–19, 1984.

    Google Scholar 

  142. An international cooperative study — second report. A survey of ultrafiltration in continuous ambulatory peritoneal dialysis. Perit Dial Bull 4: 137–142m, 1984.

    Google Scholar 

  143. Henderson IS, Couper I, Lumsden A: Potentially irritant glucose metabolites in unused CAPD fluid, In: Maher JF, Winchester JF (eds), Frontiers in Peritoneal Dialysis. New York, Field, Rich and Assoc, Inc., pp 261–264, 1986.

    Google Scholar 

  144. Arbin A: Release of chemicals from dialysis-bags and tubes of PVC-plastics. (Abstract) Perit Dial Bull 5: 90, 1985.

    Google Scholar 

  145. Heaton A, Johnston DG, Burrin JM, Orskov H, Ward MK, Alberti KGMM, Kerr DNS: Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle. Clin Sci 65: 5329–545, 1983.

    Google Scholar 

  146. Armstrong VW, Fuchs C, Scheler F: Biochemical studies on patients undergoing continuous ambulatory peritoneal dialysis. Klin Wochenschr 58: 1065–1069, 1980.

    Article  PubMed  CAS  Google Scholar 

  147. Wideröe TE, Smeby LC, Myking OL: Plasma concentrations and transperitoneal transport of native insulin and C-peptide in patients on continuous ambulatory peritoneal dialysis. Kidney Int 25: 82–87, 1984.

    Article  PubMed  Google Scholar 

  148. Armstrong VW, Creutzfeldt W, Ebert R, Fuchs C, Hilgers R, Scheler F: Effect of dialysis glucose load on plasma and glucoregulatory hormones in CAPD patients. Nephron 39: 141–145, 1985.

    Article  PubMed  CAS  Google Scholar 

  149. Lindholm B, Bergström J, Karlander SG: Glucose metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 17: 58–60, 1981.

    Google Scholar 

  150. Lindholm B, Karlander SG: Glucose tolerance in patients undergoing continuous ambulatory peritoneal dialysis. Acta Med Scand 220: 477–483, 1986.

    Article  PubMed  CAS  Google Scholar 

  151. Wathen RL, Keshaviah P, Hommeyer P, Cadwell K, Comty CM: The metabolic effects of hemodialysis with and without glucose in the dialysate. Am J Clin Nutr 31: 1870–1875, 1978.

    PubMed  CAS  Google Scholar 

  152. Hampers CL, Soeldner JS, Doak PB, Merill JP: Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest 45: 1719–1731, 1966.

    Article  PubMed  CAS  Google Scholar 

  153. Alfrey AC, Sussman KE, Holmes JH: Changes in glucose and insulin metabolism induced by dialysis in patients with chronic uremia. Metabolism 16: 733–740, 1967.

    Article  Google Scholar 

  154. Swenson RS, Weisinger J, Reavan GM: Evidence that hemodialysis does not improve the glucose intolerance of patients with chronic renal failure. Metabolism 23: 929–936, 1974.

    Article  PubMed  CAS  Google Scholar 

  155. Davidson MB, Dabir-Vaziri N, Schaffer M: Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia. Metabolism 25: 455–464, 1976.

    Article  PubMed  CAS  Google Scholar 

  156. Ferranini E, Pilo A, Tuoni M: The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis. Metabolism 28: 125–136, 1979.

    Article  Google Scholar 

  157. Marumo F, Sakai T, Sato S: Response of insulin, glucagon and growth hormone to arginine infusion in patients with chronic renal failure. Nephron 24: 81–84, 1979.

    Article  PubMed  CAS  Google Scholar 

  158. Boyer J, Gill GN, Epstein FH: Hyperglycemia and hype-rosmolality complicating peritoneal dialysis. Ann Intern Med 67:568–572, 1967.

    PubMed  CAS  Google Scholar 

  159. Nolph KD, Rosenfeld PS, Powell JT, Danforth JR E: Peritoneal glucose transport and hyperglycemia during peritoneal dialysis. Am J Med Sci 259: 272–281, 1970.

    Article  PubMed  CAS  Google Scholar 

  160. Anderson G, Bergquist-Poppen M, Bergström J, Collste LG, Hultman E; Glucose absorption from the dialysis fluid during peritoneal dialysis. Scand J Urol Nephrol 5: 77–79, 1971.

    Article  Google Scholar 

  161. Brown JD, Adam WR, Dawborn JK: Glucose absorption and hyperglycaemia during peritoneal dialysis. Aust N Z J Med 1: 1–5, 1973.

    Google Scholar 

  162. Spitz I, Rubinstein AH, Bersohn I, Lawrence AM, Kirsteins L: The effect of dialysis on the carbohydrate intolerance of chronic renal failure. Horm Metab Res 2: 86–93, 1970.

    Article  PubMed  CAS  Google Scholar 

  163. Bergström J, Fürst P: Uremic toxins, In: Drukker W, Parsons FM, Maher JF (eds), Replacement of Renal Function by Dialysis. Boston, Martinus Nijhoff Puiblishers, pp 354–390, 1983.

    Google Scholar 

  164. Bergström J: Clinical implications of middle molecules, In: Nissenson AR, Fine RN, Gentile DE (eds), Clinical dialysis. Norwalk, Connecticut, Appleton-Century-Crofts, pp 577–589, 1984.

    Google Scholar 

  165. McCaleb ML, Izzo MS, Lockwood DH: Characterization and that induces insulin resistance. J Clin Invest 75: 391–396, 1985.

    Article  PubMed  CAS  Google Scholar 

  166. Heaton A, Johnston DG, Haigh JW, Ward MK, Alberti KGMM, Kerr DNS: Twenty-four hour hormonal and metabolic profiles in ureamic patients before and during treatment with continuous ambulatory peritoneal dialysis. Clin Sci 69: 449–457, 1985.

    PubMed  CAS  Google Scholar 

  167. Kurtz SB, Wong VH, Anderson CF, Vogel JP, McCarthy JT, Mitchell JC: Continuous ambulatory peritoneal dialysis. Three years’ experience at the Mayo Clinic. Mayo Clin Proc 58: 633–639, 1983.

    PubMed  CAS  Google Scholar 

  168. De Fremont JF, Bataille P, Moriniere P, Kaczmareck P, Fievet P, Fournier A; Metabolic tolerance of continuous ambulatory peritoneal dialysis (CAPD), In: Gahl GM, Kessel M, Nolph KD (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 446–448, 1981.

    Google Scholar 

  169. Stout RW: The relationship of abnormal circulating insulin levels to atherosclerosis. Atherosclerosis 27: 1–13, 1977.

    Article  PubMed  CAS  Google Scholar 

  170. Chan NK, Varghese Z, Moorhead JF: Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 19: 625–637, 1981.

    Article  PubMed  CAS  Google Scholar 

  171. Heuck CC, Ritz E: Hyperlipoproteinemia in renal insufficiency. Nephron 25: 1–7, 1980.

    Article  PubMed  CAS  Google Scholar 

  172. Bagdade JD: Hyperlipidemia and atherosclerosis in chronic dialysis patients, In: Drukker W, Parsons FM, Maher JF (eds), Replacement of Renal Function by Dialysis. Boston, Martinus Nijhoff Publishers, pp 588–594, 1983.

    Google Scholar 

  173. Sakhrani L: Lipoprotein abnormalities in uremia, In: Nissenson AR, Fine RN, Gentile DE (eds), Clinical Dialysis. Norwalk, Connecticut, Appleton-Century-Crofts, pp 439–450, 1984.

    Google Scholar 

  174. Bagdade JD, Albers JJ: Plasma high-density lipoprotein concentrations in chronic hemodialysis and renal transplant patients. N Engl J Med 296: 1436–1439, 1977.

    Article  PubMed  CAS  Google Scholar 

  175. Brunzell JD, Albers JJ, Haas LB, Goldberg AP, Agadoa L, Sherrard DJ: Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26: 903–910, 1977.

    Article  PubMed  CAS  Google Scholar 

  176. Attman PO, Gustafson A: Lipid and carbohydrate metabolism in uraemia. Eur J Clin Invest 9: 285–291, 1979.

    Article  PubMed  CAS  Google Scholar 

  177. Ibels LS, Simons LA, King JO, Williams PF, Neale FC, Stewart JH: Studies on the nature and causes of hyperlipidemia in uremia, maintenance dialysis and renal transplantation. Q J Med 176: 601–614, 1975.

    Google Scholar 

  178. Rapaport J, Aviram M, Chaimovitz C, Brook JG: Defective high density lipoprotein composition in patients on chronic hemodialysis. N Engl J Med 299: 1326–1329, 1978.

    Article  Google Scholar 

  179. Nestel PJ, Fidge NH, Tan MH: Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 307: 329–333, 1982.

    Article  PubMed  CAS  Google Scholar 

  180. Norbeck HE, Carlson LA: The uremic dyslipoproteinemia: Its characteristics and relations to clinical factors. Acta Med Scand 209: 489–503, 1981.

    Article  PubMed  CAS  Google Scholar 

  181. Norbeck HE, Carlson LA: Increased frequency of late prebeta lipoproteins (LP-beta) in isolated serum very low density lipoproteins in uraemia. Eur J Clin Invest 10: 423–426, 1980.

    Article  PubMed  CAS  Google Scholar 

  182. Norbeck HE: Lipoprotein metabolism in chronic renal failure, In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R (eds), Lipoproteins and Coronary Atherosclerosis. Amsterdam, Elsevier Biomedical Press B.V., pp 337–342, 1982.

    Google Scholar 

  183. Norbeck HE: Serum lipoproteins in chronic renal failure (Thesis). Acta Med Scand Suppl 649: 1–49, 1981.

    PubMed  CAS  Google Scholar 

  184. Norbeck HE, Orö L, Carlson LA: Serum lipid and lipoprotein concentrations in chronic uremia. Acta Med Scand 200: 487–492, 1976.

    Article  PubMed  CAS  Google Scholar 

  185. Driieke T, Lacour B, Roullet JB, Funck-Brentano JL: Recent advances in factors that alter lipid metabolism in chronic renal failure. Kidney Int 24 (suppl 16): S134–138, 1983.

    Google Scholar 

  186. Staprans I, Felts JM, Zacherie B: Apoprotein composition in plasma lipoproteins in uremic patients on hemodialysis. Clin Chim Acta 93: 135–143, 1979.

    Article  PubMed  CAS  Google Scholar 

  187. Sniderman A, Cianflone K, Kwiterovich PO, Hutchinson T, Barre P, Prichard S: Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis. Atherosclerosis (Elsevier Scientific Publishers) 65: 257–264, 1987.

    CAS  Google Scholar 

  188. Norbeck HE, Walldius G: Fatty acid composition of serum and adipose tissue lipids in males with chronic renal failure. Acta Med Scand 211: 75–85, 1982.

    Article  PubMed  CAS  Google Scholar 

  189. Norbeck HE, Olsson AG: Effect of intravenous heparin on serum lipoprotein in uremic man, In: Lundblad RL, Brown WV, Mann KG, Roberts HR (eds), Chemistry and Biology of Heparin. Amsterdam Elsevier North Holland, Inc., pp 217–223, 1982.

    Google Scholar 

  190. Attman PO, Gustafson A, Alanpovic P, Wang CS: Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure. Am J Nephrol 4: 92–98, 1984.

    Article  PubMed  CAS  Google Scholar 

  191. Frank WM, Sreepada Rao TK, Manis T, Delano BG, Avram MM, Saxena AK, Carter AC, Friedman EA: Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis. Am J Clin Nutr 31: 1886–1892, 1978.

    PubMed  CAS  Google Scholar 

  192. Haas LB, Wahl PW, Sherrard DJ: A longitudinal study of lipid abnormalities in renal failure. Nephron 33: 145–149, 1983.

    Article  PubMed  CAS  Google Scholar 

  193. Norbeck HE, Rössner S: Intravenous fat tolerance test with intralipid in chronic renal failure. Acta Med Scand 211: 69–74, 1982.

    Article  PubMed  CAS  Google Scholar 

  194. Chan MK, Varghese Z, Persaud JW, Naillod RA, Moorhead JF: Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenic roles of triglyceride production and triglyceride removal. Clin Nephrol 17: 183–190, 1982.

    PubMed  CAS  Google Scholar 

  195. Attman PO, Gustafson A: Lipid and carbohydrate metabolism in uraemia. Eur J Clin Invest 9: 285–291, 1979.

    Article  PubMed  CAS  Google Scholar 

  196. Russel GI, Davies TG, Walls J: Evaluation of the intravenous fat tolerance test in chronic renal disease. Clin Nephrol 13: 282–286, 1980.

    Google Scholar 

  197. Olefsky J, Farquhar JW, Reavan GM: Reappraisal of the role of insulin in hyperglyceridemia. Am J Med 57: 551–560, 1974.

    Article  PubMed  CAS  Google Scholar 

  198. Coulston AM, Liu GC, Reaven GM: Plasma glucose, insulin and lipid response to high-carbohydrate low-fat diets in normal humans. Metabolism 32: 52–56, 1983.

    Article  PubMed  CAS  Google Scholar 

  199. Mancini M. Mattock M, Rabaya E, Chait A, Lewis B: Studies of the mechanisms of carbohydrate-induced lipaemia in normal man. Atherosclerosis 17: 445–454, 1973.

    Article  PubMed  CAS  Google Scholar 

  200. Lewis B: The Hyperlipidaemias. Clinical and Laboratory Practice, Oxford, Blackwell Scientific Publications, p 147, 1976.

    Google Scholar 

  201. Kannel WB, Castilli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease. New perspective based on Framingham study. Ann Intern Med 90: 85–91, 1979.

    PubMed  CAS  Google Scholar 

  202. Ron D, Oren H, Aviram M, Better OS, Brook JG: Accumulation of lipoprotein remnants in patients with chronic renal failure. Atherosclerosis 46: 67–75, 1983.

    Article  PubMed  CAS  Google Scholar 

  203. Sorge F, Castro LA, Nagel A, Kessel M: Serum glucose, insulin, growth hormone, free fatty acids and lipids responses to high carbohydrate and to high fat isocaloric diets in patients with chronic, non-nephrotic renal failure. Horm Metab Res 7: 118–127, 1975.

    Article  Google Scholar 

  204. Sanfelippo ML, Swenson RS, Reavan GM: Response of plasma triglycerides to dietary change in patients on hemodialysis. Kidney Int 14: 180–186, 1978.

    Article  PubMed  CAS  Google Scholar 

  205. Cattran DC, Steiner GS, Fenton SSA, Ampil M: Dialysis hyperlipemia: response to dietary manipulations. Clin Nephrol 13: 177–182, 1980.

    PubMed  CAS  Google Scholar 

  206. Okubo M, Tsukamoto Y, Yoneda T, Homma Y, Nakamura H, Marumo F: Deranged fat metabolism and the lowering effect of carbohydrate poor diet on serum triglycerides in patients with chronic renal failure. Nephron 25: 8–14, 1980.

    Article  PubMed  CAS  Google Scholar 

  207. Lindholm B, Alvestrand A, Fürst P, Karlander SG, Norbeck HE, Ahlberg M, Tranaeus A, Bergström J: Metabolic effects of continuous ambulatory peritoneal dialysis. Proc EDTA 17: 283–289, 1980.

    CAS  Google Scholar 

  208. Lindholm B, Bergström J, Norbeck HE: Lipoprotein (LP) metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD), In: Gahl GM, Kessel M, Nolph KD (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 434–436, 1981.

    Google Scholar 

  209. Lindholm B, Karlander SG, Norbeck HE, Bergström J: Glucose and lipid metabolism in peritoneal dialysis, In: La Greca G, Biasoli S, Ronco C (eds), Peritoneal Dialysis. Wichtig Editore, pp 219–230, 1982.

    Google Scholar 

  210. Gokal R, Ramos JM, McGurk JG, Ward MK, Kerr DNS: Hyperlipidaemia in patients on continuous ambulatory peritoneal dialysis. In: Gahl GM, Kessel M, Nolph KD (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 430–433, 1981.

    Google Scholar 

  211. Lindholm B, Norbeck HE: Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 220: 143–151, 1986.

    Article  PubMed  CAS  Google Scholar 

  212. Turgan C, Feehally J, Bennett S, Davies TJ, Walls J: Accelerated hypertriglyceridemia in patients on continuous ambulatory peritoneal dialysis — A preventable abnormality. Int JArtifOrgans4: 158–160, 1981.

    Google Scholar 

  213. Roncari DAK, Breckenridge WC, Khanna R, Oreopoulos DG: Rise in high-density lipoprotein-cholesterol in some patients treated with CAPD. Perit Dial Bull 1: 136–137, 1981.

    Google Scholar 

  214. Breckenridge WC, Roncari DAK, Khanna R, Oreopoulos DG: The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins. Atherosclerosis 45: 249–258, 1982.

    Article  PubMed  CAS  Google Scholar 

  215. Khanna R, Breckenridge C, Roncari D, Digenis G, Oreopoulos DG: Lipid abnormalities in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Bull 3 (suppl): S13–15, 1983.

    Google Scholar 

  216. Ramos JM, Heaton A, McGurk JG, Wark MK, Kerr DNS: Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis. Nephron 35: 20–23, 1983.

    Article  PubMed  CAS  Google Scholar 

  217. Nolph KD, Ryan KL, Prowant B, Twardowski Z: A cross sectional assessment of serum vitamin D and triglyceride concentrations in a CAPD population. Perit Dial Bull 4: 232–237, 1984.

    Google Scholar 

  218. Chan MK, Persaud JW, Varghese Z, Baillod RA, Moorhead JF: Postheparin lipolytic enzymes in patients on CAPD, in Frontiers in Peritoneal Dialysis, edited by Maher JF, Winchester JF, New York, Field, Rich and Assoc, Inc., p. 437–442, 1986.

    Google Scholar 

  219. Tsukamoto Y, Okubo M, Yoneda T, Marumo F, Nakamura H: Effects of a polyunsaturated fatty acid-rich diet on serum lipids in patients with chronic renal failure. Nephron 31: 236–241, 1982.

    Article  PubMed  CAS  Google Scholar 

  220. Tripathy K, Lotero H, Bolanos O: Role of dietary protein upon serum cholesterol levels in malnourished subjects. Am J Clin Nutr 23: 1160–1168,1970.

    PubMed  CAS  Google Scholar 

  221. Broyer M, Niaudet P, Champion G, Jean G, Chopin N, Czernichow P: Nutritional and metabolic studies in children on continuous ambulatory peritoneal dialysis. Kidney Int 24 (suppl 15): S106–110, 1983.

    Google Scholar 

  222. Chan MK, Baillod RA, Chuah P, Sweny P, Raftery MJ, Varghese Z, Moorhead JF: Three years’ experience of continuous ambulatory peritoneal dialysis. Lancet 1: 1409–1412, 1981.

    Article  PubMed  CAS  Google Scholar 

  223. Lindholm B, Karlander SG, Norbeck HE, Bergström J: Hormonal and metabolic adaptation to the glucose load of CAPD in non-diabetic patients, In: Keen H, Legrain M (eds), Prevention and Treatment of Diabetic Nephropathy. Boston, MTP Press Ltd, pp 353–359, 1983.

    Google Scholar 

  224. Dieplinger H, Schoenfeld PY, Fielding CJ: Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. J Clin Invest 77: 1071–1083, 1986.

    Article  PubMed  CAS  Google Scholar 

  225. Khanna R, Wu G, Vas S, Oreopoulos DG: Mortality and morbidity on continuous ambulatory peritoneal dialysis. ASAIO J 6: 197–204, 1983.

    Google Scholar 

  226. Wu G et al; Cardiovascular deaths among CAPD patients. Perit Dial Bull 3 (suppl): S23–26, 1983.

    Google Scholar 

  227. Bertoli M, Battistella PA, Vergani L, Naso A, Gasparotto ML, Romagnoli GF. Angelini C: Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. Am J Clin Nutr 34: 1496–1500, 1981.

    PubMed  CAS  Google Scholar 

  228. Cattran DC: The significance of lipid abnormalities in patients receiving dialysis therapy. Perit Dial Bull 3 (suppl): S29–32, 1983.

    Google Scholar 

  229. Gutman RA, Blumenkrantz MJ, Chan YK, Barbour GL, Gandhi VC, Shen FK, Tucker T, Murawski BJ, Coburn JW, Curtis FK: Controlled comparison of hemodialysis and peritoneal dialysis: Veterans Administration Multicenter Study. Kidney Int 26: 459–470, 1984.

    Article  PubMed  CAS  Google Scholar 

  230. Palmer RA, Newell JE, Gray ES, Quinton WE: Treatment of chronic renal failure by prolonged peritoneal dialysis. New Engl J Med 274: 248, 1966.

    Article  PubMed  Google Scholar 

  231. Bergström J, Fürst P, Noree LO: The effects of peritoneal dialysis on intracellular free amino acids in muscle from uremic patients. Proc Eur Dial Transplant Ass 9: 393, 1972.

    Google Scholar 

  232. Bergström J, Fürst P, Noree LO, Vinnars E: Intracellular free amino acids in muscle tissue of patients with chronic uremia: effect of peritoneal dialysis and infusion of essential amino acids. Clin Sci mol Med 54: 51–60, 1978.

    PubMed  Google Scholar 

  233. Schilling H, Wu G, Petit J, Harrison J, McNeil M, Siccion Z, Oreopoulos DG: Nutritional status of patients on long-term CAPD. Perit Dial Bull 5: 12–18, 1985.

    Google Scholar 

  234. Bouma SF, Dwyer JT: Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis. J Am Diet Ass 84: 194–197, 1984.

    CAS  Google Scholar 

  235. Summerfield GP, Gyde OHB, Forbes AMW, Goldsmith HJ, Bellingham AJ: Haemoglobin concentration and serum erythropoietin in renal dialysis and transplant patients. Scand J Haematol 30: 389–400, 1983.

    Article  PubMed  CAS  Google Scholar 

  236. Thomson NM, Atkins RC, Humphry TJ, Agar JM, Scott DE: Continuous ambulatory peritoneal dialysis (CAPD): an established treatment for end-stage renal failure. Aust NZ J Med 13:489–496, 1983.

    CAS  Google Scholar 

  237. Baker JP, Detsky AS, Wesson DE, Wolman SL, Stewart S, Whitewell J, Langer B, Jeejeebhoy KN: Nutritional assessment. A comparison of clinical judgement and objective measurements. New Eng J Med 306: 969–972, 1982.

    Article  PubMed  CAS  Google Scholar 

  238. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN: What is subjective global assessment of nutritional status? J Parent Ent Nutr 11: 8–13, 1987.

    Article  CAS  Google Scholar 

  239. Fenton SSA, Johnston N, Delmore T, Detsky AS, Whitewell J, O’Sullivan R, Cattran DC, Richardson RMA, Jeejeebhoy KN: Nutritional assessment of continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 33: 650–653, 1987.

    CAS  Google Scholar 

  240. Marckmann P: Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 29: 75–78, 1988.

    PubMed  CAS  Google Scholar 

  241. Panzetta G, Guerra U, D’Angelo A, Sandrini S, Terzi A, Oldrizzi L, Maiorca R: Body composition and nutritional status in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 23: 18–25, 1985.

    PubMed  CAS  Google Scholar 

  242. Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ, Kopple JD: Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 38: 599–611, 1983.

    PubMed  CAS  Google Scholar 

  243. De Santo NG, Gilli G, Capasso G, Di Leo Va, Giordano C: Growth during continuous ambulatory peritoneal dialysis (CAPD). Int J Artif Organs 5: 331–332, 1982.

    PubMed  Google Scholar 

  244. Martin-Du Pan R, Mauron C, Glaeser B, Wurtman RJ: Effect of various oral glucose doses on plasma neutral amino acid levels. Metabolism 31: 937–943, 1982.

    Article  CAS  Google Scholar 

  245. Lindholm B, Bergström J, Alvestrand A: Muscle free amino acids in patients treated with CAPD, in: Maher JF, Winchester JF (eds), Frontiers in Peritoneal Dialysis, New York, Field, Rich, and Associates, p. 400–404, 1986.

    Google Scholar 

  246. Bergström J, Lindholm B, Alvestrand A, Hultman E: Muscle composition in CAPD patients, in: La Greca G, Chiaramonte S, Fabris A, Feriani M, Ronco C (eds), Peritoneal Dialysis, Milano, Wichtig Editore, p. 107–110, 1986.

    Google Scholar 

  247. Biasioli S, D’Andrea G, Chiaramonte S, Farbis A, Feriani M, Ronco C, Borin D, Brendolan A, La Greca G: The role of neurotransmitters in the genesis of uremic encephalopathy. Int J Artif Organs 7: 101–106, 1984.

    PubMed  CAS  Google Scholar 

  248. Lindholm B, Garcia E, Qureshi GA, Henriksson S, Bergström J: High muscle and low plasma tryptophan in CAPD. (Abstract) Fifth Int Congr on Nutr and Metab in Renal Dis, Strasbourg, 1988.

    Google Scholar 

  249. Bergström J, Fürst P, Notee LO, Vinnars E: Intracellular free amino acid concentration in human muscle tissue. J Appi Physiol 36: 693–697, 1974.

    Google Scholar 

  250. Graziani G, Cantaluppi A, Casati S, Citterio A, Ponticelli C, Trifiro A, Borghi L, Sani F, Simoni I, Montanari A, Novarani A: Branched chain and aromatic free amino acids in plasma and skeletal muscle of uremic patients undergoing hemodialysis and CAPD. Int J Artif Organs 7: 85–88, 1984.

    PubMed  CAS  Google Scholar 

  251. Hayes KC: Taurine in metabolism. Ann Rev Nutr 1: 401–425, 1981.

    Article  CAS  Google Scholar 

  252. Knopf K, Sturman JA, Armstrong M, Hayes KC: Taurine: An essential nutrient for the cat. J Nutr 108: 773–778, 1978.

    PubMed  CAS  Google Scholar 

  253. Hayes KC, Stephan ZF, Sturman JA: Growth depression in taurine depleted infant monkeys. J Nutr 110: 2058–2064, 1980.

    PubMed  CAS  Google Scholar 

  254. Geggel HS, Ament ME, Heckenlively JR, Martin DA, Kopple JD: Nutritional requirements for taurine in patients receiving long-term parenteral nutrition, New Engl J Med 312: 142–146, 1985.

    Article  PubMed  CAS  Google Scholar 

  255. Alvestrand A, Fürst P, Bergström J: Intracellular amino acids in uremia. Kidney Int 24 (Suppl 16): S9-S16, 1983.

    Google Scholar 

  256. Rubin J, Barnes T, Burns P, Ray R, Teal N, Hellems E, Bower J: Comparison of home hemodialysis to continuous ambulatory peritoneal dialysis. Kidney Int 23: 51–56, 1983.

    Article  PubMed  CAS  Google Scholar 

  257. Farrell PC, Randerson DH: Comparison of CAPD with HD and IPD, in: Gahl GM, Kessel M, Nolph KD (eds), Advances in Peritoneal Dialysis. Amsterdam, Excerpta Medica, pp 131–137, 1981.

    Google Scholar 

  258. Thomson NM, Atkins RC, Humphry TJ, Agar JM, Scott DE: Continuous ambulatory peritoneal dialysis (CAPD): An established treatment for endstage renal failure. Aust N Z J Med 13: 489–496, 1983.

    PubMed  CAS  Google Scholar 

  259. Flynn MA: Nutritional problems in continuous ambulatory peritoneal dialysis. Perit Dial Bull 4 (suppl): S142–146, 1984.

    Google Scholar 

  260. Golden MH: Transport proteins as indices of protein status. Am J Clin Nutr 35: 1159–1165, 1982.

    PubMed  CAS  Google Scholar 

  261. Lunn PG, Austin S: Excess energy intake promotes the development of hypoalbuminaemia in rats fed on low-protein diets. Br J Nutr 49: 9–16, 1983.

    Article  PubMed  CAS  Google Scholar 

  262. Delmez JA, Slatopolsky E, Martin KJ, Gearing BN, Harter HR: Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis. Kidney Int 21: 862–867, 1982.

    Article  PubMed  CAS  Google Scholar 

  263. Aloni Y, Shany S, Chainovitz C: Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Min Electr Metab 9: 82–86, 1983.

    CAS  Google Scholar 

  264. Somnolos K, Berkelhammer C, Baker J, Wu G, McNamee P, Oreopoulos DG: Nutritional assessment and skeletal muscle function in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 6: 53–58, 1986.

    Google Scholar 

  265. Bergström J: Muscle electrolytes in man. (Thesis) Scand J Clin Lab Invest 14 (Suppl 68), 1962.

    Google Scholar 

    Google Scholar 

  266. Bourgoignie JJ, Jacob AI, Salman AL, Pennell JP: Water, electrolyte, and acid-base abnormalities in chronic renal failure. Seminars in Nephrol 1: 91–111, 1981.

    CAS  Google Scholar 

  267. Mitch WE, Wilcox CS: Disorders of body fluids, sodium and potassium in chronic renal failure. Amer J Med 72: 536–550, 1982.

    Article  PubMed  CAS  Google Scholar 

  268. Coles GA: Body composition in chronic renal failure. Q J Med 41: 25–47, 1972.

    PubMed  CAS  Google Scholar 

  269. Bergström J: Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609–6165, 1975.

    Article  PubMed  Google Scholar 

  270. Graham JA, Lamb JF, Linton AL: Measurement of body water and intracellular alectrolytes by means of muscle biopsy. Lancet II: 1172–1176, 1967.

    Article  Google Scholar 

  271. Bilbrey GL, Carter NW, White MG, Schilling JF, Knochel JP: Potassium deficiency in chronic renal failure. Kidney Int 4: 423–430, 1973.

    Article  PubMed  CAS  Google Scholar 

  272. Montanari A, Graziani G, Borghi L, Cantaluppi A, Simoni I, Lorenzano E, Ponticelli C, Novarini A: Skeletal muscle water and electrolytes in chronic renal failure. Effects of long-term regular dialysis treatment. Nephron 39: 316–320, 1985.

    Article  PubMed  CAS  Google Scholar 

  273. Broyer M, Delaporte C, Maziere B: Water, electrolytes and protein content of muscle obtained by needle biopsy in uremic children. Biomedicine 21: 278–285, 1974.

    PubMed  CAS  Google Scholar 

  274. Bergström J, Hultman E: Water, electrolyte and glycogen content of muscle tissue in patients undergoging regular dialysis therapy. Clin Nephrol 2: 24–33, 1974.

    PubMed  Google Scholar 

  275. Montanari A, Borghi L, Canali M, Novarinia A, Borghetti A: Studies on cell water and electrolytes in chronic renal failure. Clin Nephrol 9: 200–204, 1978.

    PubMed  CAS  Google Scholar 

  276. Cotton JR, Woodward T, Carter NW, Knochel JP: Correction of uremic cellular injury with a protein restricted, amino acid supplemented diet. Kidney Int 14: 673, 1978.

    Google Scholar 

  277. Bergström J, Alvestrand A, Fürst P, Hultman E, Widstam-Attorps U: Muscle intracellular electrolytes in patients with chronic uremia. Kidney Int 24 (suppl 16): S153–160, 1983.

    Google Scholar 

  278. Nissenson AR: Acid-base homeostasis in peritoneal dialysis patients. Int J Artif Organs 7: 175–176, 1984.

    PubMed  CAS  Google Scholar 

  279. Nolph KD, Prowant B, Serkes KD, Morgan L, Baker B, Charytan C, Gham K, Hamburger R, Husserl F, Kleit D, McGuinness J, Moore H, Warren T: Multicenter evaluation of a new peritoneal dialysis solution with a high lactate and a low magnesium concentration. Perit Dial Bull 3: 63–65, 1983.

    Google Scholar 

  280. Lameire N, Ringoir S: Introductory remarks: An overview of peritonitis and other complications of continuous ambulatory peritoneal dialysis, In: Legrain M (ed), Continuous Ambulatory Peritoneal Dialysis. Amsterdam, Excerpta Medica, p 229, 1980.

    Google Scholar 

  281. Tazamaloukas AH, Avasthi PS: Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis. Am J Nephrol 7: 101–109, 1987.

    Article  Google Scholar 

  282. Lindholm B, Alvestrand A, Hultman F, Bergström J: Muscle water and electrolytes in patients undergoing continuous ambulatory peritoneal dialysis. Acta Med Scand 219: 323–330, 1986.

    Article  PubMed  CAS  Google Scholar 

  283. Alvestrand A, Wahren J, Smith D, DeFronzo RA: Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol 246: F174–180, 1984.

    Google Scholar 

  284. Oren A, Bernhard R, Riley LJ, Mojaverian P, Ferguson RK: Effect of increased insulin secretion during CAPD on potassium metabolism, In: Maher JF, Winchester JF (eds), Peritoneal Dialysis. New York, Field, Rich and Associates Inc, pp 409–415, 1986.

    Google Scholar 

  285. Panzetta GG, Guerra U, D’Angelo A, Sandrini S, Terzi A, Oldrizzi L, Maiorca R: Body composition and nutritional status in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 23: 18–25, 1985.

    PubMed  CAS  Google Scholar 

  286. Nanninga LB: Calculation of free magnesium, calcium and potassium in muscle, Biochem Biophys Acta 54: 338–344, 1961.

    Article  PubMed  CAS  Google Scholar 

  287. Delano BG: Regular dialysis treatment, In: Drukker W, Parsons FM, Maher JF (eds), Replacement of Renal Function by Dialysis, Boston, Martinus Nijhoff Publishers, pp 391–409, 1983.

    Google Scholar 

  288. Blass CR: Adequacy of dialysis. Am J Kidney Dis 4: 218–223, 1984.

    Google Scholar 

  289. Twardowsky ZJ: Individualized dialysis for CAPD patients: a review of the experience at the University of Missouri. Uremia Invest 8: 35–43, 1984.

    Google Scholar 

  290. Bergström J, Lindblom U, Noree LO: Preservation of peripheral nerve function in severe uremia during treatment with low protein high calorie diet and surplus of essential amino acids. Acta Neurol Scand 51: 99–109, 1975.

    Article  PubMed  Google Scholar 

  291. Simmons RG, Anderson C, Kamstyra L: Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and after transplantation. Am J Kidney Dis 4: 253–255, 1984.

    PubMed  CAS  Google Scholar 

  292. Arends JP, Krediet RT, Boeschoten WE, Van der Lelie J, Veenhof CHN, Von dem Borne AEGK: Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment. Proc EDTA 18: 280–285, 1981.

    CAS  Google Scholar 

  293. Giacchino F, Alloatti S, Belardi P, Quarello F, Bosticardo GM, Pozaato M, Aprato A, Segoloni G, Piccoli G: Continuous ambulatory peritoneal dialysis and cellular immunity, In: Gahl GM, Kessel M, Nolph KD (eds), Advances in Peritoneal Dialysis. Amsterdam Excerpta Medica, pp 214–219, 1981.

    Google Scholar 

  294. Giacchino F, Pozzato M, Piccoli G: Evaluation of the influence of peritoneal dialysis on cellular immunity by the E-rosette inhibition test. Artif Organs 8: 156–160, 1984.

    Article  PubMed  CAS  Google Scholar 

  295. Summerfield GP, Gyde OHB, Forbes AMW, Goldsmith HJ, Bellingham AJ: Haemoglobin concentration and serum erythropoietin in renal dialysis and transplant patients. Scand J Haematol 30: 389–400, 1983.

    Article  PubMed  CAS  Google Scholar 

  296. De Paepe MBJ, Schelstraete KGH, Ringoir SMG, Lameire NH: Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease. Kidney Int 23: 744–748m 1983.

    Article  PubMed  Google Scholar 

  297. Zappacosta AR, Caro J, Erslev A: Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. The role of erythropoietin. Am J Med 72: 53–57, 1982.

    Article  PubMed  CAS  Google Scholar 

  298. Moldofsky H, Krueger JM, Walter J, Dinarello CA, Lue FA, Quance G, Oreopoulos DG: Sleep-promoting material extracted from peritoneal dialysate of patients with end-stage renal disease and insomnia. Perit Dial Bull 5: 189–193, 1985.

    Google Scholar 

  299. Gomez-Fernandez P, Sanchez Agudo L, Caltrava JM, Escuin F, Selgas R, Martinez ME, Monterö A, Sanchez-Sicilia L: Respiratory muscle weekness in uremic patients under continuous ambulatory peritoneal dialysis. Nephron 36: 219–223, 1984.

    Article  PubMed  CAS  Google Scholar 

  300. Quellhorst EA: Ultrafiltration and haemofiltration — practical applications; In: Drukker W, Parsons FM, Maher JF (eds), Replacement of Renal Function by Dialysis, Boston, Martinus Nijhoff Publishers, pp 265–274, 1983.

    Google Scholar 

  301. Baldamus CA, Knobloch M, Sachoeppe W, Koch KM: Hemodialysis/hemofiltration: a report of a controlled crossover study. Int J Artif Organs 3: 211–214, 1980.

    PubMed  CAS  Google Scholar 

  302. Bergström J: Serum middle molecules and CAPD. Perit Dial Bull 2: 59–61, 1982.

    Google Scholar 

  303. Randerson DH, Farceli PC: Mass transfer properties of the human peritoneum. ASAIO J 3: 140–146, 1980.

    Google Scholar 

  304. Bergström J, Asaba H, Fürst P, Lindholm B: Middle molecules in chronic uremic patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Bull 3 (suppl): S7–9, 1983.

    Google Scholar 

  305. Lindholm B, Tegnér R, Tranaeus A, Bergström J: Progress of peripheral uremic neuropathy during continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Organs 28: 263–268, 1982.

    CAS  Google Scholar 

  306. Tegner R, Lindholm B: Uremic polyneuropathy: Different effects of hemodialysis and continuous ambulatory peritoneal dialysis. Acta Med Scand, 218: 409–416, 1985.

    Article  PubMed  CAS  Google Scholar 

  307. Comty CA: Long-term dietary management of dialysis patients. J Am Diet Ass 54: 439–444, 1968.

    Google Scholar 

  308. Ginn HE, Frost A, LAry WW: Nitrogen balance in hemodialysis patients. Am J Clin Nutr 21: 385–393, 1968.

    PubMed  CAS  Google Scholar 

  309. Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, Rubini ME: Optimal dietary protein treatment during chronic hemodialysis. Trans Am Soc Artif Intern Organs 15: 302–307, 1969.

    PubMed  CAS  Google Scholar 

  310. Schaeffer G, Heinze V, Jontofsohn R, Katz N, Rippich TH, Schäfer B, Sudhoff A, Zimmerman W, Kluthe R: Amino acid and protein intake in RDT patients. A nutritional and biochemical analysis. Clin Nephrol 3: 228–233, 1975.

    PubMed  CAS  Google Scholar 

  311. Kluthe R, Luttgen FM, Capetianu T, Heinze V, Katz N, Sudhoff A: Protein requirements in maintenance hemodialysis. Am J Clin Nutr 31: 1812–1820, 1978.

    PubMed  CAS  Google Scholar 

  312. Shrimshaw NW: An analysis of past and present recommended daily allowances for protein in health and disease. New Engl J Med 294: 136–142, 1976.

    Article  Google Scholar 

  313. Kopple JD, Coburn JW: Metabolic studies of low protein diets in uremia. Medicine 52: 583–595, 1973.

    Article  PubMed  CAS  Google Scholar 

  314. Alvestrand A, Ahlberg M, Bergström J, Fürst P: Clinical results of long-term treatment with low protein diet and a new amino acid preparation in chronic uremic patients. Clin Nephrol 19: 67–73, 1983.

    PubMed  CAS  Google Scholar 

  315. Bergström J, Ahlberg M, Alvestrand A, Fürst P: Metabolic studies with keto acids in uremia. Am J Clin Nutr 31: 1761–1766, 1978.

    PubMed  Google Scholar 

  316. Simmons JM, Wilson CJ, Potter DE, Holliday MA: Relation of calorie deficiency to growth failure in children on hemodialysis and the growth failure in children on hemodialysis and the growth response to calorie supplementation. New Engl J Med 285: 653–656, 1971.

    Article  PubMed  CAS  Google Scholar 

  317. Giordano C, De Santo NG, Pluvio M, Di Leo VA, Capodicasa G, Cirillo D, Esposito R, Damiano M: Protein requirement of patients on CAPD: a study on nitrogen balance. Int J Artif Organs 3: 11–14, 1980.

    PubMed  CAS  Google Scholar 

  318. Brzostowicz M, Schoenfeld P, Kaysen G, Mapes D, Newhouse Y, Piercy L, Humphreys M: Continuous ambulatory peritoneal dialysis (CAPD): nitrogen balance is maintained or improved during initiation of therapy. (Abstract 37 A). 13th Ann Meet Am Soc of Nephrology, Washington, DC, 1980.

    Google Scholar 

  319. Gahl GM, Von Baeyer H, Averdunk R, Riedinger H, Borowzak B, Schurig R, Becker H, Kessel M: Outpatient evaluation of dietary intake and nitrogen removal in continuous ambulatory peritoneal dialysis. Ann Intern Med 94: 643–646, 1981.

    PubMed  CAS  Google Scholar 

  320. Llach F, Franklin SS, Maxwell MH: Dietary management of patients in chronic renal failure. Nephron 14: 401–412, 1975.

    Article  PubMed  CAS  Google Scholar 

  321. Philips ME, Havard J, Howard JP: Oral essential amino acid supplementation in patients on maintenance hemodialysis. Clin Nephrol 9: 241–248, 1978.

    Google Scholar 

  322. Hecking E, Köhler J, Zobel R, Lemmel EM, Mader H, Opferkuch W, Prellwitz W, Keim H J, Mûller D: Treatment with essential amino acids in patients on chronic hemodialysis: a double blind cross-over study. Am J Clin Nutr 31: 1821–1826, 1976.

    Google Scholar 

  323. Acchiardo S, Moore L, Cockrell S: Effect of essential amino acids (EAA) on chronic hemodialysis (CHD) patients (PTS). Trans Am Soc Artif Intern Organs 28: 608–613, 1982.

    PubMed  CAS  Google Scholar 

  324. Neuhäuser M, Ulm A, Leber HW, Schùtterle G: Influence of essential amino acids and keto acids on protein metabolism and the anaemia of patients on chronic intermittent haemo-dialysis. Proc Eur Dial Transplant Ass 14: 557–562, 1978.

    Google Scholar 

  325. Piraino AJ, Firpo JJ, Powers DV: Prolonged hyperalimentation in catabolic chronic dialysis therapy patients. J Parent Ent Nutr 5: 463–477, 1981.

    Article  CAS  Google Scholar 

  326. Heidland A, Kult J: Long-term effects of essential amino acid supplementation in patients on regular dialysis treatment. Clin Nephrol 3: 234–239, 1975.

    PubMed  CAS  Google Scholar 

  327. Guarnieri G, Faccini L, Lipartit T, Rainieri F, Spangaro F, Giuntini D, Toigo G, Dardi F, Berquier-Vivaldi F, Raimondi A: Simple methods for nutritional assessment in hemodialyzed patients. Am J Clin Nutr 33: 1598–1607, 1980.

    PubMed  CAS  Google Scholar 

  328. Gjessing J: Addition of amino acids to peritoneal dialysis fluid. Lancet 2: 812, 1968.

    Article  PubMed  CAS  Google Scholar 

  329. Goodship THJ, Lloyd S, McKenzie PW, Earnshaw M, Smeaton I, Bartlett K, Ward MK, Wilkinson R: Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 73: 471–478, 1987.

    PubMed  CAS  Google Scholar 

  330. Oren A, Wu G, Anderson GH, Marliss E, Khanna R, Petit J, Mupas L, Rodella H, Brandes L, Roncari DA, Kakis G, Harrison J, McNeil K, Oreopoulos DG: Effective use of amino acid dialysate over four weeks in CAPD patients. Perit Dial Bull 3: 66–73, 1983.

    Google Scholar 

  331. Pedersen EB, Dragsholt C, Laier E, Frifelt JJ, Trostman AF, Ekelund S, Paaby P: Alternate use of amino acid and glucose solutions in CAPD. Perit Dial Bull 5: 215–218, 1985.

    Google Scholar 

  332. Lindholm B, Werynski A, Bergström J: Peritoneal dialysis with amino acid solutions; Fluid and solute transport kinetics. Artif Organs 12: 2–10, 1988.

    Article  PubMed  CAS  Google Scholar 

  333. Kopple JD, Swendseid ME: Vitamin nutrition in patients undergoing maintenance hemodialysis. Kidney Int suppl 2: S79–84, 1975.

    Google Scholar 

  334. Kopple JD, Mercurio K, Blumenkrantz MJ, Jones MR, Tallos J, Roberts C, Card B, Saltzman R, Casciato DA, Swendseid ME: Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int 19: 694–704, 1981.

    Article  PubMed  CAS  Google Scholar 

  335. Blumberg A, Hanck A, Sander G: Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 20: 244–250, 1983.

    PubMed  CAS  Google Scholar 

  336. Henderson IS, Leung ACT, Shenkin A: Vitamin status in continuous ambulatory peritoneal dialysis. Perit Dial Bull 4: 143–145, 1984.

    Google Scholar 

  337. Boeschoten EW, Schrijver J, Krediet RT, Arisz L: Vitamin deficiencies in CAPD patients. Abstract. Perit Dial Bull 4: suppl S7, 1984.

    Google Scholar 

    Google Scholar 

  338. Digenis GE, Dombros N, Charytan C, Oreopoulos DG: Supplements for the CAPD patient (Vitamins, folic acid, zinc, iron, and anabolic steroids). Perit Dial Bull 7: 219–223,1987.

    Google Scholar 

  339. Moorthy AV, Rosenblum M, Rajaram R, Shug AL: A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure. Am J Nephrol 3: 205–208, 1983.

    Article  PubMed  CAS  Google Scholar 

  340. Buoncristiani U, DiPaolo N, Carobi C, Cozzari M, Quintaliani G, Bracaglia R: Carnitine depletion with CAPD, In: Gahl GM, Kessel M, Nolph KD (eds), Advances in peritoneal dialysis. Excerpta Medica, Amsterdam, pp 441–445, 1981.

    Google Scholar 

  341. Buoncristiani U, Carobi C, DiPaolo N, Cozzari M, Burgnamo R: Progression of carnitine depletion in patients on long-term CAPD. Abstract. Perit Dial Bull 4: suppl S10.

    Google Scholar 

  342. Amair P, Gregoriadis A, Rodela H, Ogilvie R, Khanna R, Brandes L, Roncari DAK, Oreopoulos DG: Serum carnitine in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 2: 11–12, 1982.

    Google Scholar 

  343. Maebashi M, Imamura A, Yosinaga K, Sato T, Funyu T, Ishidoya Y, Hirayama N: Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis. Tohoku J Exp Med 139: 33–42, 1983.

    Article  PubMed  CAS  Google Scholar 

  344. Bertoli M, Battistella PA, Vergani L, Naso A, Gasparotto ML, Romagnoli GF, Angelini C: Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. Am J Clin Nutr 34: 1496–1500, 1981.

    PubMed  CAS  Google Scholar 

  345. Guarnieri GF, Ranieri F, Toigo G, Vasile A, Climan M, Rizzoli V, Moracciello M, Campanacci L: Lipid lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Am J Clin Nutr 33: 1489–1492, 1980.

    PubMed  CAS  Google Scholar 

  346. Lacour B, Di Giulio S, Chanard J, Ciancioni C, Haguet M, Lebkiri B, Basile C, Drueke T, Assan R, Funck-Brentano JL: Carnitine improves lipid anomalies in haemodialysis patients, lancet II: 763–764, 1980.

    Google Scholar 

  347. Vacha GM, Ciorcelli G, Siliprandi N, Corsi M: Favourable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipo-protein-cholesterol. Am J Clin Nutr 38: 532–540, 1983.

    PubMed  CAS  Google Scholar 

  348. Caruso U, Cravotto E, Tisone G, Elli M, Stortoni F, D’Iddio S, Pola P. Savi L, Tondi P, Casciani CU: Long-term treatment with L-carnitine in uremic patients undergoing chronic hemodialysis: effects on the lipid pattern. Curr Ther Res 33: 1098–1104,1983.

    Google Scholar 

  349. Casciani CU, Caruso U, Cravotto E, D’Iddio S, Corsi M, Pola P, Savi L, Grilli M: L-carnitine in haemodialysed patients. Changes in lipid pattern. Arzneim Forsch Drug Res 32: 293–297, 1982.

    CAS  Google Scholar 

  350. Alfrey AC, Smythe WR: Trace metals and regular dialysis. In: Drukker W, Parsons FM, Maher JF (eds), Replacement of Renal Function by Dialysis. Martinus Nijhoff, Boston, pp 804–810, 1983.

    Google Scholar 

  351. Thomson NM, Stevens BJ, Humphrey TJ, Atkins RC. Comparison of frace elements in peritoneal dialysis, hemodialysis, and uremia. Kidney Int 23: 9–14, 1983.

    Article  PubMed  CAS  Google Scholar 

  352. Wallaeys B, Cornelis R, Lameire N: The trace elements Br, Co, Cr, Cs, Cu, Fé, Mn, Rb Se and Zn in serum, packed cells and dialysate of CAPD patients. Abstract. Perit Dial Bull 4: suppl S70, 1984.

    Google Scholar 

  353. Danielson BG, Grefberg N, Nilsson P, Weiss L: Trace elements in patients on CAPD. Abstract. Kidney Int 23: 146, 1983.

    Google Scholar 

  354. Blumenkrantz MJ, Kopple JD, Moran JK, Grodstein GP, Coburn JW: Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis. Kidney Int 20: 78–82, 1981.

    Article  PubMed  CAS  Google Scholar 

  355. Farrell PC: Kinetic modeling in peritoneal dialysis, In: Nis-senson AR, Fine RN, Gentile DE (eds), Clinical Dialysis. Norwalk, Connecticut, Appleton-Century-Crofts, pp 307–318, 1984.

    Google Scholar 

Download references

Authors
  1. Bengt Lindholm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonas Bergström
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Nephrology-MA436, University of Missouri Health Sciences Center, VA Hospital, Columbia, Missouri, 65212, USA

    Karl D. Nolph

  2. Dalton Research Center, Columbia, Missouri, 65212, USA

    Karl D. Nolph

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Lindholm, B., Bergström, J. (1989). Nutritional Management of Patients Undergoing Peritoneal Dialysis. In: Nolph, K.D. (eds) Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1085-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1085-0_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6978-6

  • Online ISBN: 978-94-009-1085-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation